Bratisl Lek Listy. 2023;124(6):407-416. doi: 10.4149/BLL_2023_062.
Obesity and metabolic syndrome (MetS) are associated with structural and functional vascular abnormalities. MetS and its components may increase arterial stiffness and the risk of cardiovascular events. However, the relationship of MetS and its components, including obesity, with arterial stiffness is still not fully understood.
In a group of 116 patients undergoing treatment for hypertension, we searched for the relationships between parameters of MetS and aortic stiffness expressed by pulse wave velocity (PWVAo). PWVAo was measured using an arteriograph working on the oscillometric principle, and pulse wave analysis (PWA) for noninvasive assessment of the parameters of central hemodynamics.
From the cluster of parameters of MetS we found a significant association between body mass index (BMI) and aortic stiffness, and between fasting plasma glucose/type 2 diabetes (FPG/T2DM) and aortic stiffness. We did not find significant relationships between other components of MetS (HDL cholesterol and triglycerides) and aortic stiffness, based on the influence of hypolipidemic therapy. Arterial stiffness increased with age and was higher in females.
Arterial stiffness was associated with age, sex, and MetS components (BMI and FPG/T2DM). Surprisingly, the parameters of dyslipidemia do not influence stiffness parameters, which can be explained by hypolipidemic therapy. The influence of hypolipidemic therapy should therefore be borne in mind when evaluating arterial tree function (Tab. 15, Ref. 62). Text in PDF www.elis.sk Keywords: obesity, fasting plasma glucose, type 2 diabetes, aortic stiffness, metabolic syndrome, arterial hypertension, cardiovascular risk.
肥胖和代谢综合征(MetS)与血管结构和功能异常有关。MetS 及其成分可增加动脉僵硬度和心血管事件风险。然而,MetS 及其成分(包括肥胖)与动脉僵硬之间的关系尚不完全清楚。
在一组 116 名接受高血压治疗的患者中,我们寻找 MetS 参数与脉搏波速度(PWVAo)表示的主动脉僵硬之间的关系。PWVAo 使用基于振荡测量原理的动脉造影仪测量,脉搏波分析(PWA)用于无创评估中心血液动力学参数。
在 MetS 的参数簇中,我们发现体重指数(BMI)与主动脉僵硬之间以及空腹血糖/2 型糖尿病(FPG/T2DM)与主动脉僵硬之间存在显著相关性。我们没有发现其他 MetS 成分(HDL 胆固醇和甘油三酯)与主动脉僵硬之间存在显著相关性,这是基于降脂治疗的影响。动脉僵硬随年龄增长而增加,女性更高。
动脉僵硬与年龄、性别和 MetS 成分(BMI 和 FPG/T2DM)有关。令人惊讶的是,血脂异常的参数不会影响僵硬参数,这可以用降脂治疗来解释。因此,在评估动脉树功能时应考虑降脂治疗的影响(表 15,参考文献 62)。